These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mechanisms of immune evasion in schistosomiasis. Pearce EJ; Sher A Contrib Microbiol Immunol; 1987; 8():219-32. PubMed ID: 3304833 [TBL] [Abstract][Full Text] [Related]
6. Immunological and Biochemical Interplay between Cytokines, Oxidative Stress and Schistosomiasis. Masamba P; Kappo AP Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281269 [TBL] [Abstract][Full Text] [Related]
7. Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population. Beechler BR; Jolles AE; Budischak SA; Corstjens PLAM; Ezenwa VO; Smith M; Spaan RS; van Dam GJ; Steinauer ML PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006122. PubMed ID: 29253882 [TBL] [Abstract][Full Text] [Related]
8. Important aspects of Biomphalaria snail-schistosome interactions as targets for antischistosome drug. El-Ansary A; Al-Daihan S Med Sci Monit; 2006 Dec; 12(12):RA282-292. PubMed ID: 17136018 [TBL] [Abstract][Full Text] [Related]
9. The schistosome in the mammalian host: understanding the mechanisms of adaptation. Kusel JR; Al-Adhami BH; Doenhoff MJ Parasitology; 2007 Oct; 134(Pt 11):1477-526. PubMed ID: 17572930 [TBL] [Abstract][Full Text] [Related]
10. The Tao survivorship of schistosomes: implications for schistosomiasis control. Cai P; Gobert GN; You H; McManus DP Int J Parasitol; 2016 Jun; 46(7):453-63. PubMed ID: 26873753 [TBL] [Abstract][Full Text] [Related]
11. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Capron A; Riveau G; Capron M; Trottein F Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662 [TBL] [Abstract][Full Text] [Related]
12. Immunological Considerations for Driciru E; Koopman JPR; Cose S; Siddiqui AA; Yazdanbakhsh M; Elliott AM; Roestenberg M Front Immunol; 2021; 12():635985. PubMed ID: 33746974 [TBL] [Abstract][Full Text] [Related]
13. Parasite glycans and antibody-mediated immune responses in Schistosoma infection. van Diepen A; Van der Velden NS; Smit CH; Meevissen MH; Hokke CH Parasitology; 2012 Aug; 139(9):1219-30. PubMed ID: 22423613 [TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni, S. japonicum, S. haematobium: glycogen content and glucose uptake in parasites from fasted and control hosts. Cornford EM; Diep CP; Rowley GA Exp Parasitol; 1983 Dec; 56(3):397-408. PubMed ID: 6641897 [TBL] [Abstract][Full Text] [Related]
16. Reverse genetics and the study of the immune response to schistosomes. Pearce EJ; Freitas TC Parasite Immunol; 2008 Apr; 30(4):215-21. PubMed ID: 18324924 [TBL] [Abstract][Full Text] [Related]
17. Conservation of CD4+ T cell-dependent developmental mechanisms in the blood fluke pathogens of humans. Lamb EW; Crow ET; Lim KC; Liang YS; Lewis FA; Davies SJ Int J Parasitol; 2007 Mar; 37(3-4):405-15. PubMed ID: 17196594 [TBL] [Abstract][Full Text] [Related]
18. Stage-specifically expressed schistosome proteins as potential chemotherapeutic targets. El-Ansary A; Al-Daihan S Med Sci Monit; 2005 Mar; 11(3):RA94-103. PubMed ID: 15735581 [TBL] [Abstract][Full Text] [Related]
19. Schistosoma genomics: new perspectives on schistosome biology and host-parasite interaction. Han ZG; Brindley PJ; Wang SY; Chen Z Annu Rev Genomics Hum Genet; 2009; 10():211-40. PubMed ID: 19630560 [TBL] [Abstract][Full Text] [Related]
20. Signalling pathways and the host-parasite relationship: putative targets for control interventions against schistosomiasis: signalling pathways and future anti-schistosome therapies. You H; Gobert GN; Jones MK; Zhang W; McManus DP Bioessays; 2011 Mar; 33(3):203-14. PubMed ID: 21290396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]